Thomas Tillis (R-NC)
Medical Supply Chain Resiliency Act
A Republican bill with 2 Democratic cosponsors · See all 3 cosponsors
Last activity — Read twice and referred to the Committee on Finance.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Medical Supply Chain Resiliency Act aims to authorize the President to enter into trade agreements with trusted partners to improve the security of medical goods. This legislation seeks to diversify supplier networks to prevent shortages seen during the COVID-19 pandemic. It provides a framework for the reciprocal elimination of duties and import restrictions on medical devices and pharmaceuticals. The bill focuses on enhancing supply chain security through regulatory cooperation and intellectual property protection. Additionally, it establishes oversight mechanisms for Congress to review and potentially disapprove these trade agreements.
Yes· 3 of 13
- Scored +8
Does this make the country readier for the next outbreak?
The bill specifically targets strengthening supply chains to prepare for future public health emergencies.
- Scored +7
Does this make trade with other countries easier?
The bill facilitates more efficient trade by reducing duties and regulatory barriers for medical goods.
- Scored +6
Does this strengthen ties with allied countries?
The bill focuses on establishing and strengthening trade relationships with trusted international partners.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved Supply Chain Security: The bill aims to diversify and expand supplier networks to ensure a reliable supply of medical goods, particularly during emergency situations. (Section 3, Purpose 2 and 3)
-
Reduced Trade Barriers: It seeks to eliminate unnecessary trade barriers and distortions that can disrupt or weaken medical supply chains. (Section s 3, Purpose 4)
-
Faster Movement of Goods: The act intends to expedite the cross-border movement of critical medical goods. (Section 3, Purpose 5)
-
Increased Research and Development: The framework promotes international collaboration and encourages new investments in research and development for medical goods. (Section 3, Purpose 6)
-
Enhanced Regulatory Efficiency: By promoting regulatory cooperation and the adoption of good regulatory practices, the bill aims to streamline the movement of medical devices and pharmaceutical goods. (Section 3, Purpose 7 and 10)
Potential Negative Impacts for People
- Risk of Economic Disincentives: The bill notes that duties and trade barriers can exist to prevent disincentivizing research, development, and manufacturing within the United States. (Section 5, Subsection c, Paragraph 1)
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make the country readier for the next outbreak? — The bill specifically targets strengthening supply chains to prepare for future public health emergencies. Does this make health care easier to get in general? — The bill aims to improve healthcare access by ensuring a reliable supply of medical goods during emergencies. Does this put more money into medical research? — The bill fosters international collaboration to encourage new investments in medical research and development.
- National Security And Foreign Policy
- Does this make trade with other countries easier? — The bill facilitates more efficient trade by reducing duties and regulatory barriers for medical goods. Does this strengthen ties with allied countries? — The bill focuses on establishing and strengthening trade relationships with trusted international partners. Does this favour talking over confrontation abroad? — The bill utilizes trade agreements as a tool for international cooperation on public health and security.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill includes requirements for presidential reports to Congress to ensure transparency. Does this give the federal government more power? — The bill expands the President's authority to negotiate specific trade agreements for medical goods.
- Education And Technology
- Does this make patent and copyright rules fairer? — The bill emphasizes the protection of intellectual property rights within trade agreements. Does this put more money into scientific research? — The bill encourages investment in research and development through international cooperation.
- Demographic And Interest Groups
- Would business owners be better off under this? — The bill benefits businesses in the medical and pharmaceutical sectors by reducing trade barriers.
- Environment Energy And Infrastructure
- Does this improve help for people hit by a disaster? — By securing medical supplies, the bill supports better preparedness for public health disasters.
- Economy And Finance
- Does this give people more protection from unfair business practices? — The bill enhances consumer protection by securing the supply of critical medical goods.
- 3/12/2025
- Read twice and referred to the Committee on Finance.
- 3 Cosponsors added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Michael BennetDemocrat · Colorado
John CornynRepublican · Texas
Christopher CoonsDemocrat · Delaware